PATRICIA KEHOE: Open Payments
NPI 1821735150 · PALOS HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 38 payments from 23 companies in 2025. Trend: 2023 $692 · 2024 $823 · 2025 $1,148
Food & beverage: $963Education: $185
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $149 |
| Janssen Biotech, Inc. | 4 | $121 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| Tempus AI, Inc | 1 | $89 |
| SOBI, INC | 1 | $85 |
| Celgene Corporation | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Astellas Pharma US Inc | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Alexion Pharmaceuticals, Inc. | 2 | $43 |
Products named: Enhertu, XT CDX, Doptelet, REBLOZYL, TALVEY, ULTOMIRIS, LIBTAYO, RYBREVANT.
Industry payments across IL — which companies pay providers there.
